Deerfield Special Situations Fund, L.P.
CIK 1354395 · last filed 2019-10-30
Deerfield Special Situations Fund, L.P. is a corporate insider who has filed 37 SEC Form 4 insider transactions across 20 companies since 2007. The most recent filing, for CABA, was dated Oct 30, 2019. Across all open-market trades the lifetime net is +$754.4M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $276.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$276.91M
20
37
$754.43M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CABA | 10%+ Owner | 700,000 | $2.73 | $1.91M | $53.90M | 1 | 2019-10-30 |
| Korro Bio, Inc. (FREQ) Delisted | 10%+ Owner | 9,457 | $14.98 | $141.7K | $28.00M | 1 | 2019-10-07 |
| ACRS | 3,159,165 | $5.33 | $16.84M | -$19.84M | 3 | 2019-07-01 | |
| XERS | 10%+ Owner | 873,520 | $8.24 | $7.20M | -$11.93M | 2 | 2019-02-07 |
| CBIO | 10%+ Owner | 74,215 | $16.44 | $1.22M | -$8.76M | 1 | 2018-03-08 |
| RYTM | 10%+ Owner | 468,505 | $108.04 | $50.62M | $36.21M | 1 | 2017-10-10 |
| AXGN | 10%+ Owner | 3,000,000 | $41.15 | $123.45M | -$2.74M | 1 | 2016-07-21 |
| EHTH | 10%+ Owner | 1,062,874 | $1.36 | $1.45M | -$17.47M | 1 | 2016-06-22 |
| STREAMLINE HEALTH SOLUTIONS INC. (STRM) Delisted | 10%+ Owner | 125,033 | $5.33 | $666.8K | -$1.95M | 1 | 2015-12-17 |
| CTMX | 10%+ Owner | 160,512 | $3.22 | $516.8K | $45.00M | 1 | 2015-10-14 |
| ANTARES PHARMA, INC. (ATRS) Delisted | 10%+ Owner | 7,037,014 | $5.59 | $39.34M | -$10.29M | 1 | 2015-06-26 |
| Auspex Pharmaceuticals, Inc. (ASPX) Delisted | 10%+ Owner | 953,286 | — | — | $736.80M | 2 | 2015-01-28 |
| Dicerna Pharmaceuticals Inc (DRNA) Delisted | 10%+ Owner | 293,949 | $38.22 | $11.23M | -$21.95M | 1 | 2014-11-25 |
| DUSA | 10%+ Owner | 1,278,032 | $57.68 | $73.72M | -$4.36M | 2 | 2011-03-22 |
| NeuroMetrix, Inc. (NURO) Delisted | 10%+ Owner | 13 | $4.58 | $60 | -$2.24M | 1 | 2010-09-17 |
| NxStage Medical, Inc. (NXTM) Delisted | 10%+ Owner | 1,231,478 | — | — | -$9.89M | 3 | 2009-12-15 |
| NITROMED INC (NTMD) Delisted | 10%+ Owner | 3,580,090 | — | — | $449.5K | 4 | 2008-08-06 |
| DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | 10%+ Owner | — | $15.50 | — | $0 | 2 | 2008-06-30 |
| INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | 10%+ Owner | 413,293 | — | — | -$21.83M | 1 | 2007-05-02 |
| THIRD WAVE TECHNOLOGIES INC /WI (TWTI) Delisted | 10%+ Owner | 1,763,136 | — | — | -$12.68M | 3 | 2007-04-27 |
Recent Filings
37 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-10-30 | CABA | Mixed | +11,399,542 | $53.90M | EDGAR |
| 2019-10-07 | Korro Bio, Inc. (FREQ) Delisted | Mixed | +8,620,038 | $28.00M | EDGAR |
| 2019-07-01 | ACRS | Sell (S) | −3,497,375 | -$9.41M | EDGAR |
| 2019-06-25 | ACRS | Sell (S) | −2,271,305 | -$10.43M | EDGAR |
| 2019-02-07 | XERS | Sell (S) | −88,842 | -$1.33M | EDGAR |
| 2019-01-25 | XERS | Sell (S) | −686,664 | -$10.60M | EDGAR |
| 2019-01-18 | ACRS | Other (J) | — | $0 | EDGAR |
| 2018-03-08 | CBIO | Sell (S) | −287,112 | -$8.76M | EDGAR |
| 2017-10-10 | RYTM | Mixed | +5,622,060 | $36.21M | EDGAR |
| 2016-07-21 | AXGN | Sell (S) | −408,544 | -$2.74M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.